All Photos
No.9005 Binhe Avenue,Futian District,Shenzhen,Guangdong
WASHINGTON, Nov. 1, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, has just released the 1-year outcome of LuX-Valve Plus TRAVEL II study at 2024 Transcatheter Cardiovascular Therapeutics Conference (TCT 2024) by on October 29th in Washington, D.C., U.S..
TRAVEL II study aims to evaluate the long-term safety and efficacy of LuX-Valve Plus in the application on patients with severe tricuspid regurgitation (TR) and high surgical risk. The clinical trial enrolled 96 patients from 15 centers in China. The results showed that the device success rate was about 97%, and the average device operation time was around 35.56 minutes.
Safety results showed that the incidence of composite events remained low at 12.50%.
Efficacy results showed that TR grade, NYHA classification, and QoL improved significantly and continuously. At 1 year,
Professor Juan F. Granada concluded that LuX-Valve Plus system is a versatile TTVR device that does not depend on radial force for anchoring. Its innovative design (ventricular septal anchor & leaflet-grasping clips) provides optional mechanisms for anchoring and stability. The multicenter, TRAVEL II study showed that LuX-Valve Plus system is safe and effective in achieving short delivery times, low 1-year composite event rates, significant TR reduction and improvement in functional and QoL metrics at 1 year.
Additional studies in Europe and the U.S. using the LuX-Valve Plus system are underway, and more clinical results are expected to be released in the future. The Company is continuously advancing the global application of LuX-Valve series system to help more TR patients. As of the latest update, over 600 implantation cases have been completed worldwide with the LuX-Valve series products, and the longest follow-up record has been over 6 years.
No.9005 Binhe Avenue,Futian District,Shenzhen,Guangdong
Disclaimer: We are partners of Ctrip (including Tongcheng Elong, Qunar,Zhuna, etc.), booking, Agoda and Expedia. We only provide BBHŌL S Hotel (Shenzhen Futian Convention and Exhibition Center) online booking service for you. Your reservation will be forwarded to the hotel by Ctrip, Tongcheng Elong and other partners. If there are problems such as liquidated damages, Tongcheng ELong or Ctrip will deduct the money and transfer it to the hotel, We are not the official website of BBHŌL S Hotel (Shenzhen Futian Convention and Exhibition Center), please know.
All rights reserved | 深圳中濠S酒店 ◎ BBHŌL S Hotel (Shenzhen Futian Convention and Exhibition Center)